348 related articles for article (PubMed ID: 8157096)
1. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
Sharir M; Pierce WM; Chen D; Zimmerman TJ
Exp Eye Res; 1994 Jan; 58(1):107-16. PubMed ID: 8157096
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
J Med Chem; 1999 Jul; 42(14):2641-50. PubMed ID: 10411484
[TBL] [Abstract][Full Text] [Related]
3. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
Brechue WF; Maren TH
Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Synthesis of topically effective intraocular pressure lowering agents derived from 5-(omega-aminoalkylcarboxamido)-1,3,4-thiadiazole-2-sulfonamide.
Barboiu M; Supuran CT; Menabuoni L; Scozzafava A; Mincione F; Briganti F; Mincione G
J Enzyme Inhib; 2000; 15(1):23-46. PubMed ID: 10850953
[TBL] [Abstract][Full Text] [Related]
5. On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor.
Sugrue MF; Gautheron P; Schmitt C; Viader MP; Conquet P; Smith RL; Share NN; Stone CA
J Pharmacol Exp Ther; 1985 Feb; 232(2):534-40. PubMed ID: 3838190
[TBL] [Abstract][Full Text] [Related]
6. pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors.
Brechue WF; Maren TH
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2581-7. PubMed ID: 8325759
[TBL] [Abstract][Full Text] [Related]
7. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.
Scozzafava A; Briganti F; Mincione G; Menabuoni L; Mincione F; Supuran CT
J Med Chem; 1999 Sep; 42(18):3690-700. PubMed ID: 10479300
[TBL] [Abstract][Full Text] [Related]
10. Ocular disposition of aminozolamide in the rabbit eye.
Putnam ML; Schoenwald RD; Duffel MW; Barfknecht CF; Segarra TM; Campbell DA
Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1373-82. PubMed ID: 3610554
[TBL] [Abstract][Full Text] [Related]
11. Topical carbonic anhydrase inhibitors: a new perspective in glaucoma therapy.
Hiett JA; Dockter CA
Optom Clin; 1992; 2(4):97-112. PubMed ID: 1286242
[TBL] [Abstract][Full Text] [Related]
12. The effect of cyclooxygenase inhibition on the ocular hypotensive action of topical carbonic anhydrase inhibitors in rabbits.
Sugrue MF; O'Neill-Davis L
J Ocul Pharmacol; 1991; 7(3):201-11. PubMed ID: 1783853
[TBL] [Abstract][Full Text] [Related]
13. The effects of carbonic anhydrase inhibitors on aqueous humor chemistry and dynamics.
Bar-Ilan A; Pessah NI; Maren TH
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1198-205. PubMed ID: 6434487
[TBL] [Abstract][Full Text] [Related]
14. Characterization of arylamine acetyltransferase in the rabbit eye.
Campbell DA; Schoenwald RD; Duffel MW; Barfknecht CF
Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2190-200. PubMed ID: 2071333
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?
Borras J; Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
Bioorg Med Chem; 1999 Nov; 7(11):2397-406. PubMed ID: 10632049
[TBL] [Abstract][Full Text] [Related]
16. Ocular penetration and hypotensive activity of the topically applied carbonic anhydrase inhibitor L-645,151.
Bar-Ilan A; Pessah NI; Maren TH
J Ocul Pharmacol; 1986; 2(2):109-20. PubMed ID: 3503100
[TBL] [Abstract][Full Text] [Related]
17. Ocular pharmacology of methazolamide analogs: distribution in the eye and effects on pressure after topical application.
Maren TH; Bar-Ilan A; Caster KC; Katritzky AR
J Pharmacol Exp Ther; 1987 Apr; 241(1):56-63. PubMed ID: 3106616
[TBL] [Abstract][Full Text] [Related]
18. 2-Substituted 1, 3, 4-thiadiazole-5-sulfonamides as carbonic anhydrase inhibitors: their effects on the transepithelial potential difference of the isolated rabbit ciliary body and on the intraocular pressure of the living rabbit eye.
Kishida K; Miwa Y; Iwata C
Exp Eye Res; 1986 Dec; 43(6):981-95. PubMed ID: 3817035
[TBL] [Abstract][Full Text] [Related]
19. Studies of topical carbonic anhydrase inhibitors: ocular hypotensive effect of thiadiazole derivatives.
Chiang CH; Lee AR; Lin CH
J Ocul Pharmacol; 1993; 9(2):109-15. PubMed ID: 8345284
[TBL] [Abstract][Full Text] [Related]
20. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.
Russell KR; Wang DR; Potter DE
Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
